Press release

Business Wire2 March 2026

Lone Star Funds Completes Sale of SPX FLOW to ITT Inc.

DALLAS & NEW YORK & LONDON & TOKYO–(BUSINESS WIRE)–Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone…
Read More »
Business Wire2 March 2026

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

NEW YORK–(BUSINESS WIRE)–The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined…
Read More »
Press Release

Cision PR Newswire2 March 2026

YY Group Malaysia Subsidiary to Grow Retail Promoter Workforce Fivefold, Targeting US$14 Million in 2026 Revenue

Strategic Expansion Deepens Retail Sector Penetration, Strengthening and Diversifying Revenue Pipeline SINGAPORE, March 2, 2026 /PRNewswire/ — YY Group Holding…
Read More »
Cision PR Newswire2 March 2026

Spinogenix Announces FRAXA Research Foundation Support for PIs Leading Phase 2b Trial of Investigational Therapy SPG601 for People with Fragile X Syndrome (FXS)

SPG601 is a first-in-class, BK-modulator with the potential to improve cognitive, emotional and sensory symptoms in FXS patients LOS ANGELES,…
Read More »
Press Release

Cision PR Newswire2 March 2026

XTI Aerospace’s Drone Nerds Business Expands Creality Line with New SPARKX i7 3D Printer

AI-assisted setup and operation, integrated filament switching system provide accessible out-of-the-box experience ENGLEWOOD, Colo., March 2, 2026 /PRNewswire/ — XTI…
Read More »
Press Release

Cision PR Newswire2 March 2026

Cellebrite Completes Acquisition of Drone Forensics Leader SCG Canada, Inc.

Addition of Unmanned Aerial Vehicle (UAV) forensic capabilities extends Cellebrite’s AI-powered platform to one of the fastest-growing data sources in…
Read More »
Press Release

Cision PR Newswire2 March 2026

Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial

Enrolled 35 of the 70 patients in the ongoing NEPHRO-CRRT registrational study, supported by new target profile sites Company to…
Read More »
Press Release

Cision PR Newswire2 March 2026

Xtalks Announces its Life Science Webinar Calendar for March 2026

Upcoming free, educational webinars from Xtalks will feature topics in cell and gene therapy, clinical trials, commercialization & HEOR, drug…
Read More »
Cision PR Newswire2 March 2026

AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn’s Disease

In the Phase 3 AFFIRM study in adults with moderately to severely active Crohn’s disease, risankizumab (SKYRIZI®) achieved superiority for the…
Read More »
Press Release

Cision PR Newswire2 March 2026

Jack Henry Executives Set to Speak at Upcoming Investor Conferences

MONETT, Mo., March 2, 2026 /PRNewswire/ — Jack Henry® (Nasdaq: JKHY) announced today that it will be participating in several upcoming…
Read More »

Previous page Next page